Mechanical Thrombectomy With and Without Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke: A Systematic Review and Meta-Analysis Using Nested Knowledge
Background: Mechanical thrombectomy (MT) is now the standard-of-care treatment for acute ischemic stroke (AIS) of the anterior circulation and may be performed irrespective of intravenous tissue plasminogen activator (IV-tPA) eligibility prior to the procedure. This study aims to understand better i...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-12-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fneur.2021.759759/full |
_version_ | 1819238822323421184 |
---|---|
author | Gautam Adusumilli John M. Pederson John M. Pederson Nicole Hardy Kevin M. Kallmes Kristen Hutchison Hassan Kobeissi Daniel M. Heiferman Jeremy J. Heit |
author_facet | Gautam Adusumilli John M. Pederson John M. Pederson Nicole Hardy Kevin M. Kallmes Kristen Hutchison Hassan Kobeissi Daniel M. Heiferman Jeremy J. Heit |
author_sort | Gautam Adusumilli |
collection | DOAJ |
description | Background: Mechanical thrombectomy (MT) is now the standard-of-care treatment for acute ischemic stroke (AIS) of the anterior circulation and may be performed irrespective of intravenous tissue plasminogen activator (IV-tPA) eligibility prior to the procedure. This study aims to understand better if tPA leads to higher rates of reperfusion and improves functional outcomes in AIS patients after MT and to simultaneously evaluate the functionality and efficiency of a novel semi-automated systematic review platform.Methods: The Nested Knowledge AutoLit semi-automated systematic review platform was utilized to identify randomized control trials published between 2010 and 2021 reporting the use of mechanical thrombectomy and IV-tPA (MT+tPA) vs. MT alone for AIS treatment. The primary outcome was the rate of successful recanalization, defined as thrombolysis in cerebral infarction (TICI) scores ≥2b. Secondary outcomes included 90-day modified Rankin Scale (mRS) 0–2, 90-day mortality, distal embolization to new territory, and symptomatic intracranial hemorrhage (sICH). A separate random effects model was fit for each outcome measure.Results: We subjectively found Nested Knowledge to be highly streamlined and effective at sourcing the correct literature. Four studies with 1,633 patients, 816 in the MT+tPA arm and 817 in the MT arm, were included in the meta-analysis. In each study, patient populations consisted of only tPA-eligible patients and all imaging and clinical outcomes were adjudicated by an independent and blinded core laboratory. Compared to MT alone, patients treated with MT+tPA had higher odds of eTICI ≥2b (OR = 1.34 [95% CI: 1.10; 1.63]). However, there were no statistically significant differences in the rates of 90-day mRS 0-2 (OR = 0.98 [95% CI: 0.77; 1.24]), 90-day mortality (OR = 0.94 [95% CI: 0.67; 1.32]), distal emboli (OR = 0.94 [95% CI: 0.25; 3.60]), or sICH (OR = 1.17 [95% CI: 0.80; 1.72]).Conclusions: Administering tPA prior to MT may improve the rates of recanalization compared to MT alone in tPA-eligible patients being treated for AIS, but a corresponding improvement in functional and safety outcomes was not present in this review. Further studies looking at the role of tPA before mechanical thrombectomy in different cohorts of patients could better clarify the role of tPA in the treatment protocol for AIS. |
first_indexed | 2024-12-23T13:42:20Z |
format | Article |
id | doaj.art-2132f6fc73bf4900a2fda947780f901b |
institution | Directory Open Access Journal |
issn | 1664-2295 |
language | English |
last_indexed | 2024-12-23T13:42:20Z |
publishDate | 2021-12-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Neurology |
spelling | doaj.art-2132f6fc73bf4900a2fda947780f901b2022-12-21T17:44:49ZengFrontiers Media S.A.Frontiers in Neurology1664-22952021-12-011210.3389/fneur.2021.759759759759Mechanical Thrombectomy With and Without Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke: A Systematic Review and Meta-Analysis Using Nested KnowledgeGautam Adusumilli0John M. Pederson1John M. Pederson2Nicole Hardy3Kevin M. Kallmes4Kristen Hutchison5Hassan Kobeissi6Daniel M. Heiferman7Jeremy J. Heit8Department of Radiology and Neurosurgery, Stanford University, Stanford, CA, United StatesNested Knowledge, Inc, St. Paul, MN, United StatesSuperior Medical Experts, Inc, St. Paul, MN, United StatesNested Knowledge, Inc, St. Paul, MN, United StatesNested Knowledge, Inc, St. Paul, MN, United StatesNested Knowledge, Inc, St. Paul, MN, United StatesCentral Michigan University College of Medicine, Mt. Pleasant, MI, United StatesSemmes-Murphey Clinic, Department of Neurosurgery, Memphis, TN, United StatesDepartment of Radiology and Neurosurgery, Stanford University, Stanford, CA, United StatesBackground: Mechanical thrombectomy (MT) is now the standard-of-care treatment for acute ischemic stroke (AIS) of the anterior circulation and may be performed irrespective of intravenous tissue plasminogen activator (IV-tPA) eligibility prior to the procedure. This study aims to understand better if tPA leads to higher rates of reperfusion and improves functional outcomes in AIS patients after MT and to simultaneously evaluate the functionality and efficiency of a novel semi-automated systematic review platform.Methods: The Nested Knowledge AutoLit semi-automated systematic review platform was utilized to identify randomized control trials published between 2010 and 2021 reporting the use of mechanical thrombectomy and IV-tPA (MT+tPA) vs. MT alone for AIS treatment. The primary outcome was the rate of successful recanalization, defined as thrombolysis in cerebral infarction (TICI) scores ≥2b. Secondary outcomes included 90-day modified Rankin Scale (mRS) 0–2, 90-day mortality, distal embolization to new territory, and symptomatic intracranial hemorrhage (sICH). A separate random effects model was fit for each outcome measure.Results: We subjectively found Nested Knowledge to be highly streamlined and effective at sourcing the correct literature. Four studies with 1,633 patients, 816 in the MT+tPA arm and 817 in the MT arm, were included in the meta-analysis. In each study, patient populations consisted of only tPA-eligible patients and all imaging and clinical outcomes were adjudicated by an independent and blinded core laboratory. Compared to MT alone, patients treated with MT+tPA had higher odds of eTICI ≥2b (OR = 1.34 [95% CI: 1.10; 1.63]). However, there were no statistically significant differences in the rates of 90-day mRS 0-2 (OR = 0.98 [95% CI: 0.77; 1.24]), 90-day mortality (OR = 0.94 [95% CI: 0.67; 1.32]), distal emboli (OR = 0.94 [95% CI: 0.25; 3.60]), or sICH (OR = 1.17 [95% CI: 0.80; 1.72]).Conclusions: Administering tPA prior to MT may improve the rates of recanalization compared to MT alone in tPA-eligible patients being treated for AIS, but a corresponding improvement in functional and safety outcomes was not present in this review. Further studies looking at the role of tPA before mechanical thrombectomy in different cohorts of patients could better clarify the role of tPA in the treatment protocol for AIS.https://www.frontiersin.org/articles/10.3389/fneur.2021.759759/fullstrokethrombectomytissue plasminogen activatorthrombolysismeta-analysissemi-automated analysis |
spellingShingle | Gautam Adusumilli John M. Pederson John M. Pederson Nicole Hardy Kevin M. Kallmes Kristen Hutchison Hassan Kobeissi Daniel M. Heiferman Jeremy J. Heit Mechanical Thrombectomy With and Without Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke: A Systematic Review and Meta-Analysis Using Nested Knowledge Frontiers in Neurology stroke thrombectomy tissue plasminogen activator thrombolysis meta-analysis semi-automated analysis |
title | Mechanical Thrombectomy With and Without Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke: A Systematic Review and Meta-Analysis Using Nested Knowledge |
title_full | Mechanical Thrombectomy With and Without Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke: A Systematic Review and Meta-Analysis Using Nested Knowledge |
title_fullStr | Mechanical Thrombectomy With and Without Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke: A Systematic Review and Meta-Analysis Using Nested Knowledge |
title_full_unstemmed | Mechanical Thrombectomy With and Without Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke: A Systematic Review and Meta-Analysis Using Nested Knowledge |
title_short | Mechanical Thrombectomy With and Without Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke: A Systematic Review and Meta-Analysis Using Nested Knowledge |
title_sort | mechanical thrombectomy with and without intravenous tissue plasminogen activator for acute ischemic stroke a systematic review and meta analysis using nested knowledge |
topic | stroke thrombectomy tissue plasminogen activator thrombolysis meta-analysis semi-automated analysis |
url | https://www.frontiersin.org/articles/10.3389/fneur.2021.759759/full |
work_keys_str_mv | AT gautamadusumilli mechanicalthrombectomywithandwithoutintravenoustissueplasminogenactivatorforacuteischemicstrokeasystematicreviewandmetaanalysisusingnestedknowledge AT johnmpederson mechanicalthrombectomywithandwithoutintravenoustissueplasminogenactivatorforacuteischemicstrokeasystematicreviewandmetaanalysisusingnestedknowledge AT johnmpederson mechanicalthrombectomywithandwithoutintravenoustissueplasminogenactivatorforacuteischemicstrokeasystematicreviewandmetaanalysisusingnestedknowledge AT nicolehardy mechanicalthrombectomywithandwithoutintravenoustissueplasminogenactivatorforacuteischemicstrokeasystematicreviewandmetaanalysisusingnestedknowledge AT kevinmkallmes mechanicalthrombectomywithandwithoutintravenoustissueplasminogenactivatorforacuteischemicstrokeasystematicreviewandmetaanalysisusingnestedknowledge AT kristenhutchison mechanicalthrombectomywithandwithoutintravenoustissueplasminogenactivatorforacuteischemicstrokeasystematicreviewandmetaanalysisusingnestedknowledge AT hassankobeissi mechanicalthrombectomywithandwithoutintravenoustissueplasminogenactivatorforacuteischemicstrokeasystematicreviewandmetaanalysisusingnestedknowledge AT danielmheiferman mechanicalthrombectomywithandwithoutintravenoustissueplasminogenactivatorforacuteischemicstrokeasystematicreviewandmetaanalysisusingnestedknowledge AT jeremyjheit mechanicalthrombectomywithandwithoutintravenoustissueplasminogenactivatorforacuteischemicstrokeasystematicreviewandmetaanalysisusingnestedknowledge |